Study on Human Cytomegalovirus Proteins - specifically on 65 kDa protein -
Study on Human Cytomegalovirus Proteins - specifically on 65 kDa protein -
批准号:
63570214
负责人:
FURUKAWA Toru
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989
中文摘要
65 kDa的巨细胞病毒蛋白被认为是位于衣壳和外膜之间的一个模糊的区域--病毒粒子被层。对65 kDa蛋白的抗原性分析进行了两年的研究,结果如下。用抗65 kDa蛋白的单特异性抗体和单抗进行免疫荧光试验,以监测该蛋白在感染细胞中的表达。结果:1.无论单抗的反应性有何差异,所有染色的胞浆内包涵体均定位于HCMV诱导的免疫球蛋白Fc部分受体的部位,提示与HCMV共定位的65 kDa抗体可诱导FCR,且具有多种不同的抗原决定簇。结果表明,130、65、50和36 kDa的FCR蛋白参与了Ig G的结合。阻断实验证实了65 kDa抗体与Ig G Fc结合的特异性。我们研究了HCMV诱导的IgGFCR与65 kDa蛋白上的B_2微球蛋白受体的关系。用SV-8水解酶对65 kDa蛋白进行酶切,得到6个多肽。用65 kDa的单抗和单特异性抗体定位消化后的多肽上的抗原决定簇。存在Ig G FCR的kDa为33、32和28的多肽也能与B_2m结合,提示B_2m与Ig G Fc具有相同的结合部位。
英文摘要
The 65 kDa HCMV protein has been considered a constitute of the virion tegument, a poorly defined area located between the capsid and the outer membrane.The study toward analysis of antigenicity of the 65 kDa protein during 2 years has revealed the results as follows.1. Immunofluorescence assay using monospecific and monoclonal antibodies to the 65 kDa protein was carried out to monitor the expression of this protein in infected cells. Regardless of differences in the reactivity of the monoclonal antibodies, all stained cytoplasmic inclusion bodies localized to the site of the HCMV induced receptor for the Fc portion of IgG, suggesting that of the 65 kDa colocalized with HCMV induced FcR and had several different antigenic determinants.2. FcR species of 130, 65, 50 and 36 kDa proteins were found to mediate the binding of IgG. The specificity of binding with of the 65 kDa with IgG Fc were confirmed by the blocking experiments.3. We investigated the relationship between IgG FcR induced by HCMV and B_2 microglobulin receptor on the 65 kDa protein. Digestion of the 65 kDa protein with SV-8 protease generated six peptides. Monoclonal and monospecific antibodies to the 65 kDa were used to map the antigenic determinants on the digested peptides. Peptides with kDa of 33, 32 and 28 on which IgG FcR existed could also be bound by B_2m suggesting that B_2m shares the same binding sites with IgG Fc.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K. Shimokawa, Xu Bin, T. Furukawa.: "Comparative study with monospecific and monoclonal antibodies against a 65K human cytomegalovirus protein." Archives of Virology, 101, 79-86, 1988.
K. Shimokawa、Xu Bin、T. Furukawa.:“针对 65K 人类巨细胞病毒蛋白的单特异性和单克隆抗体的比较研究。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Murayama,T.Furukawa,et al: "Biological response modifier enhances the activity of natural killer cell against human cytomegalovirus-infected cells" Journal of Medical Virology. 29. 102-108 (1989)
T.Murayama、T.Furukawa 等人:“生物反应调节剂增强自然杀伤细胞针对人类巨细胞病毒感染细胞的活性”《医学病毒学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Xu-Bin,T.Takagami,T.Furukawa: "Human cytomegalovirus increases the expression of class I HLA at the late stage of infection"
Xu-Bin,T.Takagami,T.Furukawa:“人类巨细胞病毒在感染后期增加I类HLA的表达”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Furukawa,et al: "β_2 microglobulin receptor is located on a major human cytomegalovirus protein 65 kDa sharing the site of IgG Fc receptor"
T. Furukawa 等人:“β_2 微球蛋白受体位于主要的人类巨细胞病毒蛋白 65 kDa 上,与 IgG Fc 受体共享位点”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T. Furukawa.: "Cytomegalovirus vaccine." Clinical Virology, 17, 23-29, 1989.
T. Furukawa:“巨细胞病毒疫苗。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Identification of susceptible genes in familial pancreatic cancer in Japan
-
批准号:24390090
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2012
-
负责人:FURUKAWA Toru
-
依托单位:
Identification of molecular targets associated with activation of GPCR signal pathway in pancreatic cancer
-
批准号:24659167
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:FURUKAWA Toru
-
依托单位:
Identification of molecular targets for human pancreatic cancer
-
批准号:19390106
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:FURUKAWA Toru
-
依托单位:
Curing of pancreatic cancer by DUSPG/MKP-3
-
批准号:15590295
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:FURUKAWA Toru
-
依托单位:
Experimental gene therapy employing DUSP6/MKP-3 for pancreatic cancer
-
批准号:13670161
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:FURUKAWA Toru
-
依托单位:
Identification of tumor suppressor genes by means of a genomic clone-transfer
-
批准号:11671147
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:FURUKAWA Toru
-
依托单位:
Establishment of efficient treatment strategies for the pancreatic cancer based on its molecular characteristics
-
批准号:10557116
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:1998
-
负责人:FURUKAWA Toru
-
依托单位:
Influence of Fracture Bhehvoir on the Rotating Bending Fatigue Properties of Sureface Hardened Steel
-
批准号:60460201
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$5.57万
-
财政年份:1985
-
负责人:FURUKAWA Toru
-
依托单位: